Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression

20 Jun 2022

Abstract excerpt

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD), one of the most common human monogenic diseases, is characterized by the presence of numerous fluid-filled renal cysts and is a leading cause of end-stage renal disease (ESRD). Urinary biomarkers may be useful for predicting the variable course of ADPKD progression from cyst growth to ESRD. METHODS: To identify candidate urinary biomarkers of ADPKD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone and Dental Protein Studies
Share to Genetic and Kidney Cyst Diseases
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35791741
DOI: 10.23876/j.krcp.21.303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progressionPMID 35791741Read ↗

Kidney: polycystic kidney diseaseSemantic proximity Read ↗

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networksSemantic proximity Read ↗

New treatment paradigms for ADPKD: moving towards precision medicine.Semantic proximity Read ↗

Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.Semantic proximity Read ↗

Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney diseaseSemantic proximity Read ↗

Translational research in ADPKD: lessons from animal models.Semantic proximity Read ↗

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)Semantic proximity Read ↗

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Apelin inhibits cyst growth and improves kidney function in mice with polycystic kidney diseaseSemantic proximity Read ↗

Urine MicroRNA as Potential Biomarkers of Autosomal Dominant Polycystic Kidney Disease Progression: Description of miRNA Profiles at BaselineSemantic proximity Read ↗

Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.Semantic proximity Read ↗

Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.